Found: 15
Select item for more details and to access through your institution.
Jaccoud-type lupus arthropathy.
- Published in:
- Lupus, 2022, v. 31, n. 4, p. 398, doi. 10.1177/09612033221082908
- By:
- Publication type:
- Article
Meibomian gland alteration in patients with systemic lupus erythematosus.
- Published in:
- Lupus, 2022, v. 31, n. 4, p. 407, doi. 10.1177/09612033221079760
- By:
- Publication type:
- Article
Helminth products modulate innate immune recognition of nucleic acids in systemic lupus erythematosus.
- Published in:
- Lupus, 2022, v. 31, n. 4, p. 415, doi. 10.1177/09612033221080548
- By:
- Publication type:
- Article
Clinical pharmacology considerations for the approval of belimumab for the treatment of adult patients with active lupus nephritis: A regulatory perspective.
- Published in:
- Lupus, 2022, v. 31, n. 4, p. 424, doi. 10.1177/09612033221079771
- By:
- Publication type:
- Article
Description of damage in different clusters of patients with antiphospholipid syndrome.
- Published in:
- Lupus, 2022, v. 31, n. 4, p. 433, doi. 10.1177/09612033221079781
- By:
- Publication type:
- Article
A home-based exercise program during COVID-19 pandemic: Perceptions and acceptability of juvenile systemic lupus erythematosus and juvenile idiopathic arthritis adolescents.
- Published in:
- Lupus, 2022, v. 31, n. 4, p. 443, doi. 10.1177/09612033221083273
- By:
- Publication type:
- Article
Should asymptomatic bacteriuria be treated in lupus nephritis?
- Published in:
- Lupus, 2022, v. 31, n. 4, p. 457, doi. 10.1177/09612033221083272
- By:
- Publication type:
- Article
The relation of CD4 + CD25+Foxp3+ regulatory T cells concentration with disease activity and damage index in systemic lupus erythematosus.
- Published in:
- Lupus, 2022, v. 31, n. 4, p. 463, doi. 10.1177/09612033221083269
- By:
- Publication type:
- Article
Increased CD69+CCR7+ circulating activated T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials.
- Published in:
- Lupus, 2022, v. 31, n. 4, p. 472, doi. 10.1177/09612033221084093
- By:
- Publication type:
- Article
Serum and urinary galectin-9 and C-X-C motif chemokine ligand 10.
- Published in:
- Lupus, 2022, v. 31, n. 4, p. 482, doi. 10.1177/09612033221082907
- By:
- Publication type:
- Article
Use of telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak: The 6-month results of a randomized controlled trial.
- Published in:
- Lupus, 2022, v. 31, n. 4, p. 488, doi. 10.1177/09612033221084515
- By:
- Publication type:
- Article
Systemic lupus erythematosus/ANCA-associated vasculitis overlap: An explanation for atypical lupus manifestation.
- Published in:
- Lupus, 2022, v. 31, n. 4, p. 495, doi. 10.1177/09612033221084519
- By:
- Publication type:
- Article
Recurrent brachial plexopathy as initial presentation of systemic lupus erythematosus: A case report and review of the literature.
- Published in:
- Lupus, 2022, v. 31, n. 4, p. 500, doi. 10.1177/09612033221086127
- By:
- Publication type:
- Article
A pharmacoeconomic study comparing the use of mycophenolate mofetil or cyclophosphamide as induction therapy in lupus nephritis patients in Egypt.
- Published in:
- Lupus, 2022, v. 31, n. 4, p. 505, doi. 10.1177/09612033221083270
- By:
- Publication type:
- Article
Association of juvenile systemic lupus erythematosus and retinal vasculitis: Genetic aspects.
- Published in:
- 2022
- By:
- Publication type:
- Letter